GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (MIL:1ABBV) » Definitions » Equity-to-Asset

AbbVie (MIL:1ABBV) Equity-to-Asset : 0.04 (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AbbVie Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. AbbVie's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €5,435 Mil. AbbVie's Total Assets for the quarter that ended in Sep. 2024 was €129,223 Mil. Therefore, AbbVie's Equity to Asset Ratio for the quarter that ended in Sep. 2024 was 0.04.

The historical rank and industry rank for AbbVie's Equity-to-Asset or its related term are showing as below:

MIL:1ABBV' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.15   Med: 0.08   Max: 0.12
Current: 0.04

During the past 13 years, the highest Equity to Asset Ratio of AbbVie was 0.12. The lowest was -0.15. And the median was 0.08.

MIL:1ABBV's Equity-to-Asset is ranked worse than
89.17% of 1043 companies
in the Drug Manufacturers industry
Industry Median: 0.6 vs MIL:1ABBV: 0.04

AbbVie Equity-to-Asset Historical Data

The historical data trend for AbbVie's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Equity-to-Asset Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.09 0.09 0.11 0.12 0.08

AbbVie Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.05 0.05 0.04

Competitive Comparison of AbbVie's Equity-to-Asset

For the Drug Manufacturers - General subindustry, AbbVie's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where AbbVie's Equity-to-Asset falls into.



AbbVie Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

AbbVie's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=9500.12/123529.987
=0.08

AbbVie's Equity to Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

Equity to Asset (Q: Sep. 2024 )=Total Stockholders Equity/Total Assets
=5434.832/129223.222
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AbbVie  (MIL:1ABBV) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


AbbVie Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of AbbVie's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie Business Description

Comparable Companies
Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

AbbVie Headlines

No Headlines